The cancer immunotherapy market is bracing for its next growth phase as bispecific T-cell engagers gain momentum, according ...

Q2 2025 Earnings Call Transcript August 7, 2025 Operator: Good day, and thank you for standing by. Welcome to the Arcutis ...

An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy ...

Children with moderate/more extensive atopic dermatitis treated with ruxolitinib cream achieved significant disease control ...

Flattery has been an effective tool with the president. In addition to the concessions won by Cook and Apple, Jensen Huang, CEO of semiconductor company Nvidia, has lavished praise on Trump’s vision ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the Most Undervalued Long Term Stocks to Buy According to Hedge Funds ...

The close-knit South Shore village scored points for its strong public schools, quick commute to NYC and nearby beach access, ...

More than two dozen At Home stores are set to close by the end of September as the company continues to deal with dwindling sales and crippling debt.

No revenue reported as clinical programs remain in precommercial stages. Workforce and cost reductions are expected to extend cash runway into the fourth quarter of 2026. Adicet Bio (NASDAQ:ACET), a ...

The fundraise will help advance a cancer therapy that’s already shown early promise in people whose cancers haven’t responded ...

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.